HypertensionNCT07529834
Additional Effects of Pilates Breathing and Diaphragmatic Breathing Combined With Moderate Intensity Continuous Cycling Training on Blood Pressure, Chest Expansion, Pulmonary Function and Quality Of Life in Patients With Hypertension
A study testing Cycling Training (Moderate-intensity continuous training), Pilates Breathing and Diaphragmatic Breathing in people with Hypertension, run by Foundation University Islamabad at 1 site in Pakistan.
Trial summary
Hypertension or high blood pressure is defined as when the pressure in the blood vessels is too high. According to Joint National Committee 8 (JNC 8) Guidelines, hypertension is defined as systolic blood pressure level of more than ≥ 140 mmHg and diastolic blood pressure ≥ 90 mmHg. Read more about this study
- Who is it for?
- Ages 20 to 55 years
- Conditions the study is for
- Hypertension
- What is being tested?
- Cycling Training (Moderate-intensity continuous training), Pilates Breathing and Diaphragmatic Breathing
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 45 participants
- Where
- 1 sitePakistan
- Study dates
- 12 Jan 2026to 15 May 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 55 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- Medically diagnosed patients having Stage 1 hypertension(SBP;140-159 mmHg,DBP:90-99mmHg) and Stage 2 -hypertension(SBP:≥160mmHg,DBP:≥100mmHg) according to JNC 8 Guidelines, referred by a medical specialist or GP or cardiologist from FFH or clinical setups or Hospitals of Rawalpindi/Islambad
- Patients who are on antihypertensive medications for at least 3 months before study.
- Age ranging from 20-55 years
- Both male and female patients.
- Patients who are willing to participate in exercise regime and are able to -provide informed consent, have not been a part of any exercise regime from the last 6 months and well tolerated for exercise after being screened through PAR-Q+
Who cannot join
- Patients with Stage 3 hypertension (SBP: ≥180 mmHg or DBP: ≥110 mmHg) and above hypertension according to JNC 8 Guidelines or Hypertensive Crisis etc.
- Patients with any severe knee or other orthopedic conditions that can limit exercise performance
- Patients with uncontrolled hypertension
- History of any abdominal, orthopedic or spinal surgery that could interfere with core or breathing exercise
- Neurological or psychiatric disorders
- Uncontrolled cardiovascular conditions such as arrhythmias or recent myocardial infarction
- Pregnant women
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Pakistan1 site, 1 recruiting
- Recruiting
Foundation University, Islamabad
Islamabad
Sana Bashir, PhD*, +923218529475, drsana.bashir@fui.edu.pk
About this study
Hypertension or high blood pressure is defined as when the pressure in the blood vessels is too high. According to Joint National Committee 8 (JNC 8) Guidelines, hypertension is defined as systolic blood pressure level of more than ≥ 140 mmHg and diastolic blood pressure ≥ 90 mmHg. This study aims to study the combined effects of Pilates breathing, Diaphragmatic breathing and Moderate Intensity Continuous Cycling Training on blood pressure, chest expansion, pulmonary function and quality of life. Aerobic physical activity moderate intensity continuous training: (55%- 70% of maximal heart rate (MHR), rate of perceived exertion (RPE) of 11-13 on the Borg scale) continuous training, known as MICT. Pilates breathing exercise enhances lung expansion by focusing on controlled rhythmic breathing methods involving respiratory muscles. Diaphragmatic breathing exercise is slow and controlled deep breathing that has important effects on respiratory system by the modulation of autonomic nervous system. Hypertensive patients will be selected for this study. The study will include three groups. One group will undergo Cycling training with Pilates breathing and the other group will undergo Cycling training with Diaphragmatic breathing and third group will undergo Cycling training only. Before initiating the intervention at the baseline, following outcome measures would be assessed for all the patients: Blood pressure, chest expansion, pulmonary function and quality of life.
Read the detailed description
Hypertension or high blood pressure is defined as when the pressure in the blood vessels is too high. According to Joint National Committee 8 (JNC 8) Guidelines, hypertension is defined as systolic blood pressure level of more than ≥ 140 mmHg and diastolic blood pressure ≥ 90 mmHg. Elevated blood pressure increases the heart's workload and it causes the heart to work harder and become stiffened and thick. High blood pressure can significantly impact a patient's quality of life. These impacts range from physical limitations and emotional distress to increased risk of severe health issues. Lifestyle modifications and exercise can help counteract its effects. This study aims to study the combined effects of Pilates breathing, Diaphragmatic breathing and Moderate Intensity Continuous Cycling Training on blood pressure, chest expansion, pulmonary function and quality of life. Three Parallel arm randomized control study consisting of three groups each group will contain 15 patients. Selection of subjects will be done by using non-probability purposive sampling technique.The sample size was calculated using G* power software version 3.1. This was determined for difference between two means (one-way ANOVA / Kruskal Wallis test), with significance level of 0.05 and power 0.95, which resulted in 45 participants to be enrolled in the study (15 in each group). Following tools will be used for assessment of outcome measures:
Sphygmomanometer (ICC = 0.91-0.97): To assess systolic and diastolic blood pressure.
Spirometry (ICC: 0.88-0.96): A diagnostic test used to assess lung function and help diagnose, monitor, and manage respiratory conditions. It measures the volume of air a person can inhale and exhale and how quickly they can do so. It measures FVC, FEV1 and FEV1/FVC ratio.
MINICHAL Questionnaire (ICC: 0.88,0.85): A useful and reliable instrument used to assess Quality of Life (QoL) in hypertensive patients. It is a short,16 question, self-administered questionnaire that explores both psychological and somatic aspects related to the impact of hypertension on a person's life.
Borg Scale (ICC: 0.7-0.9) It is a scale to measure rate of perceived exertion, a subjective method to measure the intensity of physical activity.The scale ranges from 6 to 20 with each number corresponding to subjective level of exertion Measuring Tape for Chest Expansion (ICC = 0.82-0.91): To measure chest expansion at xiphoid level Pulse Oximeter (ICC: 0.95): The pulse Oximeter is a non-invasive device, which provide digital readings: heart rate and oxygen saturation.
Participants will be selected according to non-probability purposive sampling technique and then randomly allocated to intervention group or control group through sealed envelope method. Single Blinded study (Participants will be kept blinded through sealed envelope method).A sealed envelope method will be used to ensure concealed allocation. Envelopes will be prepared in advance, shuffled thoroughly, and selected by the participants to determine group assignment.
This study involves 3 intervention groups naming:
GROUP A: Pilates Breathing+ Cycling GROUP B: Diaphragmatic Breathing + Cycling GROUP C: Cycling only. Following a total of 18 sessions over the course of 6 weeks period. Warm-up: Side bends, arm circles, torso twists, standing march. Cool-down: Quadriceps stretch, seated figure of four stretches, calf stretch.
Cycling Training (All Groups):
Protocol: Moderate-Intensity Continuous Training (MICT).
Parameters:
Frequency: 3 days/week Intensity: 60-79% of Maximum Heart Rate (HRmax), or Borg RPE 11-13. Progression: Based on structured Astrand-Rhyming cycle ergometer protocol guidelines.
Duration: As per the standard moderate-intensity cycling session duration (gradually increased if required).
Monitoring: Continuous heart rate and vitals monitoring throughout the cycling sessions.
Pilates breathing :
Focus: Lateral rib cage expansion, diaphragmatic control, core engagement. Position: Sitting or lying down.
Steps:
Neutral spine position. Hands placed on rib cage and abdomen. Inhale deeply expanding the ribs laterally.
Exhale drawing the navel inward to engage core muscles. Controlled breathing coordinated with warm-up and cool-down movements. Frequency: 3 days per week Intensity: Low intensity, the perceived effort should be 3-4/10 Time: 10-15 min/session Type: Lateral breathing exercises
Diaphragmatic breathing:
Focus: Deep abdominal breathing, enhancing diaphragmatic movement, autonomic balance.
Position: Supine or seated.
Steps:
Place one hand on chest and one below the ribs. Inhale slowly through the nose expanding the abdomen. Exhale through pursed lips, allowing the abdomen to fall inward. Chest should remain still. Frequency: 3 days per week Intensity: Low intensity, the perceived effort should be 3-4/10 Time: 10-15 min/session Type: Seated or supine diaphragmatic breathing (inhale deeply through the nose, exhale slowly through pursed lips) to enhance lung function, reduce stress Data will be analyzed using SPSS v. 21.0.
- Conditions
- Hypertension
- Being tested
- Cycling Training (Moderate-intensity continuous training), Pilates Breathing, Diaphragmatic Breathing
- Keywords
- Hypertension, Pilates Breathing, Diaphragmatic Breathing, Cycling training, Pulmonary Function, Chest expansion, Quality of life
- Medical subject headings
- Hypertension
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Cycling Training (Moderate-intensity continuous training)Other
Moderate-intensity continuous cycling training performed at 60-79% of maximum heart rate for 20-35 minutes, three sessions per week for six weeks.
Pilates BreathingOther
Controlled lateral breathing technique focusing on rib cage expansion and core activation performed for 10-15 minutes. A 06 weeks protocol will be followed.
Diaphragmatic BreathingOther
Slow deep breathing emphasizing diaphragmatic movement performed for 10-15 minutes.
A 06 weeks protocol will be followed.
| Study group | Role | What they receive |
|---|---|---|
| Cycling training with Pilates breathing | Experimental | Participants will perform moderate-intensity continuous cycling training with Pilates breathing exercise three times per week for six weeks. Receives: Other: Pilates Breathing |
| Cycling training with diaphragmatic breathing | Experimental | Participants will perform moderate-intensity continuous cycling training combined with diaphragmatic breathing exercise three times per week for six weeks. Receives: Other: Diaphragmatic Breathing |
| Cycling training | Active comparator | Participants will perform moderate-intensity continuous cycling training only, three times per week for six weeks. Receives: Other: Cycling Training (Moderate-intensity continuous training) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Blood Pressure (SBP and DBP)
Evaluation will be performed using a sphygmomanometer to measure Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP). Measurements will be recorded in millimeters of mercury (mmHg) under standardized conditions after at least 5 minutes of seated rest.
Two readings will be taken, and the average value will be used for analysis
Measured: 06 weeks
Chest Expansion
Evaluation will be performed by measuring chest expansion at the xiphoid level using a measuring tape. Chest circumference will be recorded in centimeters (cm) at maximum inspiration and maximum expiration, and chest expansion will be calculated as the difference between these two measurements.
Higher values indicate greater chest wall mobility and improved respiratory function, whereas lower values indicate restricted chest expansion.
Measured: 06 weeks
Pulmonary Function Test
Evaluation will be performed using a spirometer device according to standard guidelines. The parameters assessed will include Forced Expiratory Volume in 1 second (FEV₁), Forced Vital Capacity (FVC), and FEV₁/FVC ratio. Values will be recorded in liters (L) and as percentage of predicted values (%) based on age, sex, height, and ethnicity.
Higher values of FEV₁ and FVC indicate better pulmonary function, while a higher FEV₁/FVC ratio indicates reduced airway obstruction and improved respiratory status.
Measured: 06 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Apr 2026
- Study start12 Jan 2026
- Primary completion15 May 2026 (estimated)
- Study completion15 May 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for HypertensionStudies of the same condition, open and under way.
- More trials run by Foundation University IslamabadThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- This is a randomized controlled trial having three groups. One group (interventional group) wil perform Pilates breathing along with moderate-intensity continuous cycling training, and the second group (experimental group) will perform diaphragmatic breathing along with moderate-intensity continuous cycling training, and the third group (control group) will perform only moderate-intensity continuous cycling training
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 45 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Foundation University Islamabad
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07529834
- Sponsor's protocol ID
- FUCP/CTR/2026/03
- Status last verified
- Mar 2026
- First submitted
- 27 Mar 2026
- Last updated
- 14 Apr 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 14 Apr 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Additional Effects of Pilates Breathing and Diaphragmatic Breathing Combined With Moderate Intensity Continuous Cycling Training on Blood Pressure, Chest Expansion, Pulmonary Function and Quality Of Life in Patients With Hypertension
- ClinicalTrials.gov ID
- NCT07529834
- Acronym / sponsor ID
- FUCP/CTR/2026/03
- Conditions
- Hypertension
- Keywords
- Hypertension, Pilates Breathing, Diaphragmatic Breathing, Cycling training, Pulmonary Function, Chest expansion, Quality of life
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 45 participants (estimated)
- Lead sponsor
- Foundation University IslamabadUniversity, hospital or other
- Study start
- 12 Jan 2026 (actual)
- Primary completion
- 15 May 2026 (estimated)
- Study completion
- 15 May 2026 (estimated)
- First posted
- 14 Apr 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Hypertension or high blood pressure is defined as when the pressure in the blood vessels is too high. According to Joint National Committee 8 (JNC 8) Guidelines, hypertension is defined as systolic blood pressure level of more than ≥ 140 mmHg and diastolic blood pressure ≥ 90 mmHg. This study aims to study the combined effects of Pilates breathing, Diaphragmatic breathing and Moderate Intensity Continuous Cycling Training on blood pressure, chest expansion, pulmonary function and quality of life. Aerobic physical activity moderate intensity continuous training: (55%- 70% of maximal heart rate (MHR), rate of perceived exertion (RPE) of 11-13 on the Borg scale) continuous training, known as MICT. Pilates breathing exercise enhances lung expansion by focusing on controlled rhythmic breathing methods involving respiratory muscles. Diaphragmatic breathing exercise is slow and controlled deep breathing that has important effects on respiratory system by the modulation of autonomic nervous system. Hypertensive patients will be selected for this study. The study will include three groups. One group will undergo Cycling training with Pilates breathing and the other group will undergo Cycling training with Diaphragmatic breathing and third group will undergo Cycling training only. Before initiating the intervention at the baseline, following outcome measures would be assessed for all the patients: Blood pressure, chest expansion, pulmonary function and quality of life.
Detailed description
Hypertension or high blood pressure is defined as when the pressure in the blood vessels is too high. According to Joint National Committee 8 (JNC 8) Guidelines, hypertension is defined as systolic blood pressure level of more than ≥ 140 mmHg and diastolic blood pressure ≥ 90 mmHg. Elevated blood pressure increases the heart's workload and it causes the heart to work harder and become stiffened and thick. High blood pressure can significantly impact a patient's quality of life. These impacts range from physical limitations and emotional distress to increased risk of severe health issues. Lifestyle modifications and exercise can help counteract its effects. This study aims to study the combined effects of Pilates breathing, Diaphragmatic breathing and Moderate Intensity Continuous Cycling Training on blood pressure, chest expansion, pulmonary function and quality of life. Three Parallel arm randomized control study consisting of three groups each group will contain 15 patients. Selection of subjects will be done by using non-probability purposive sampling technique.The sample size was calculated using G* power software version 3.1. This was determined for difference between two means (one-way ANOVA / Kruskal Wallis test), with significance level of 0.05 and power 0.95, which resulted in 45 participants to be enrolled in the study (15 in each group). Following tools will be used for assessment of outcome measures:
Sphygmomanometer (ICC = 0.91-0.97): To assess systolic and diastolic blood pressure.
Spirometry (ICC: 0.88-0.96): A diagnostic test used to assess lung function and help diagnose, monitor, and manage respiratory conditions. It measures the volume of air a person can inhale and exhale and how quickly they can do so. It measures FVC, FEV1 and FEV1/FVC ratio.
MINICHAL Questionnaire (ICC: 0.88,0.85): A useful and reliable instrument used to assess Quality of Life (QoL) in hypertensive patients. It is a short,16 question, self-administered questionnaire that explores both psychological and somatic aspects related to the impact of hypertension on a person's life.
Borg Scale (ICC: 0.7-0.9) It is a scale to measure rate of perceived exertion, a subjective method to measure the intensity of physical activity.The scale ranges from 6 to 20 with each number corresponding to subjective level of exertion Measuring Tape for Chest Expansion (ICC = 0.82-0.91): To measure chest expansion at xiphoid level Pulse Oximeter (ICC: 0.95): The pulse Oximeter is a non-invasive device, which provide digital readings: heart rate and oxygen saturation.
Participants will be selected according to non-probability purposive sampling technique and then randomly allocated to intervention group or control group through sealed envelope method. Single Blinded study (Participants will be kept blinded through sealed envelope method).A sealed envelope method will be used to ensure concealed allocation. Envelopes will be prepared in advance, shuffled thoroughly, and selected by the participants to determine group assignment.
This study involves 3 intervention groups naming:
GROUP A: Pilates Breathing+ Cycling GROUP B: Diaphragmatic Breathing + Cycling GROUP C: Cycling only. Following a total of 18 sessions over the course of 6 weeks period. Warm-up: Side bends, arm circles, torso twists, standing march. Cool-down: Quadriceps stretch, seated figure of four stretches, calf stretch.
Cycling Training (All Groups):
Protocol: Moderate-Intensity Continuous Training (MICT).
Parameters:
Frequency: 3 days/week Intensity: 60-79% of Maximum Heart Rate (HRmax), or Borg RPE 11-13. Progression: Based on structured Astrand-Rhyming cycle ergometer protocol guidelines.
Duration: As per the standard moderate-intensity cycling session duration (gradually increased if required).
Monitoring: Continuous heart rate and vitals monitoring throughout the cycling sessions.
Pilates breathing :
Focus: Lateral rib cage expansion, diaphragmatic control, core engagement. Position: Sitting or lying down.
Steps:
Neutral spine position. Hands placed on rib cage and abdomen. Inhale deeply expanding the ribs laterally.
Exhale drawing the navel inward to engage core muscles. Controlled breathing coordinated with warm-up and cool-down movements. Frequency: 3 days per week Intensity: Low intensity, the perceived effort should be 3-4/10 Time: 10-15 min/session Type: Lateral breathing exercises
Diaphragmatic breathing:
Focus: Deep abdominal breathing, enhancing diaphragmatic movement, autonomic balance.
Position: Supine or seated.
Steps:
Place one hand on chest and one below the ribs. Inhale slowly through the nose expanding the abdomen. Exhale through pursed lips, allowing the abdomen to fall inward. Chest should remain still. Frequency: 3 days per week Intensity: Low intensity, the perceived effort should be 3-4/10 Time: 10-15 min/session Type: Seated or supine diaphragmatic breathing (inhale deeply through the nose, exhale slowly through pursed lips) to enhance lung function, reduce stress Data will be analyzed using SPSS v. 21.0.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 3
- Model description
- This is a randomized controlled trial having three groups. One group (interventional group) wil perform Pilates breathing along with moderate-intensity continuous cycling training, and the second group (experimental group) will perform diaphragmatic breathing along with moderate-intensity continuous cycling training, and the third group (control group) will perform only moderate-intensity continuous cycling training
| Arm | Type | Receives |
|---|---|---|
| Cycling training with Pilates breathing | Experimental | Other: Pilates BreathingParticipants will perform moderate-intensity continuous cycling training with Pilates breathing exercise three times per week for six weeks. |
| Cycling training with diaphragmatic breathing | Experimental | Other: Diaphragmatic BreathingParticipants will perform moderate-intensity continuous cycling training combined with diaphragmatic breathing exercise three times per week for six weeks. |
| Cycling training | Active comparator | Other: Cycling Training (Moderate-intensity continuous training)Participants will perform moderate-intensity continuous cycling training only, three times per week for six weeks. |
Who may qualify
- Ages
- 20 to 55 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (5 listed)
- Medically diagnosed patients having Stage 1 hypertension(SBP;140-159 mmHg,DBP:90-99mmHg) and Stage 2 -hypertension(SBP:≥160mmHg,DBP:≥100mmHg) according to JNC 8 Guidelines, referred by a medical specialist or GP or cardiologist from FFH or clinical setups or Hospitals of Rawalpindi/Islambad
- Patients who are on antihypertensive medications for at least 3 months before study.
- Age ranging from 20-55 years
- Both male and female patients.
- Patients who are willing to participate in exercise regime and are able to -provide informed consent, have not been a part of any exercise regime from the last 6 months and well tolerated for exercise after being screened through PAR-Q+
Key exclusion criteria (7 listed)
- Patients with Stage 3 hypertension (SBP: ≥180 mmHg or DBP: ≥110 mmHg) and above hypertension according to JNC 8 Guidelines or Hypertensive Crisis etc.
- Patients with any severe knee or other orthopedic conditions that can limit exercise performance
- Patients with uncontrolled hypertension
- History of any abdominal, orthopedic or spinal surgery that could interfere with core or breathing exercise
- Neurological or psychiatric disorders
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Cycling Training (Moderate-intensity continuous training)Moderate-intensity continuous cycling training performed at 60-79% of maximum heart rate for 20-35 minutes, three sessions per week for six weeks. | Other | Cycling training |
| Pilates BreathingControlled lateral breathing technique focusing on rib cage expansion and core activation performed for 10-15 minutes. A 06 weeks protocol will be followed. | Other | Cycling training with Pilates breathing |
| Diaphragmatic BreathingSlow deep breathing emphasizing diaphragmatic movement performed for 10-15 minutes. A 06 weeks protocol will be followed. | Other | Cycling training with diaphragmatic breathing |
Primary outcome
Blood Pressure (SBP and DBP)
Time frame: 06 weeks
Evaluation will be performed using a sphygmomanometer to measure Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP). Measurements will be recorded in millimeters of mercury (mmHg) under standardized conditions after at least 5 minutes of seated rest. Two readings will be taken, and the average value will be used for analysis
Chest Expansion
Time frame: 06 weeks
Evaluation will be performed by measuring chest expansion at the xiphoid level using a measuring tape. Chest circumference will be recorded in centimeters (cm) at maximum inspiration and maximum expiration, and chest expansion will be calculated as the difference between these two measurements. Higher values indicate greater chest wall mobility and improved respiratory function, whereas lower values indicate restricted chest expansion.
Pulmonary Function Test
Time frame: 06 weeks
Evaluation will be performed using a spirometer device according to standard guidelines. The parameters assessed will include Forced Expiratory Volume in 1 second (FEV₁), Forced Vital Capacity (FVC), and FEV₁/FVC ratio. Values will be recorded in liters (L) and as percentage of predicted values (%) based on age, sex, height, and ethnicity. Higher values of FEV₁ and FVC indicate better pulmonary function, while a higher FEV₁/FVC ratio indicates reduced airway obstruction and improved respiratory status.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 Apr 2026.
Related trials for Hypertension
Active, not recruiting
Digital Reinforcement of Motivational Interviewing Micro-Skills Among Primary Care Healthcare Professionals
Hypertension (Without Type 2 Diabetes Mellitus)
Recruiting
Investigating Vascular Properties of HEMI and SPG Signals in Individuals With or at Risk for Chronic Kidney Disease
Chronic Kidney Disease, Hypertension (HTN)
Recruiting
Trial Phase: Syndemic Adapted Medly Uganda
Mental Health
Not yet recruitingPhase 2/3
An Open-Label Extension Study to Evaluate Inhaled Treprostinil SMI in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD)
Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease
Enrolling by invitation
Testing Implementation Strategies to Support Clinic Fidelity to an Outpatient Hypertension Bundle
Pregnancy Related, Hypertension
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Cycling Training (Moderate-intensity continuous training), Pilates Breathing and Diaphragmatic Breathing in people with Hypertension, run by Foundation University Islamabad at 1 site in Pakistan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 14 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Saba Rehman, MSPT-CPT (03295200871, sabarehman278@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Blood Pressure (SBP and DBP) (time frame: 06 weeks). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Apr 2026.